Our Company
About Saadia Pharmaceuticals
Our Team
Corporate Compliance
Our Science
Our Pipeline
News
Investors
Contact Us
Menu
Our Company
About Saadia Pharmaceuticals
Our Team
Corporate Compliance
Our Science
Our Pipeline
News
Investors
Contact Us
Contact Us
News
In The News
Posters & Publications
Press Releases
September 10, 2024
In The News
Saadia Pharmaceuticals’ Team Gets Published in Nature
Learn More
September 6, 2024
In The News
Saadia Pharmaceuticals’ Team Featured in Yale Psychiatry News
Learn More
August 7, 2024
In The News
Saadia Pharmaceuticals’ Team Delivers NEI Podcast Discussing Vraylar®(Abbvie).
Learn More
July 27, 2024
Posters & Publications
Saadia Pharmaceuticals’ Team Publishes Spravato® (Janssen) Review Article in Biomarkers in Neuropsychiatry
Learn More
June 7, 2024
Posters & Publications
Saadia Pharmaceuticals’ Team Gives Presentation to 900K Prescribers on Vumedi
Learn More
May 15, 2024
Posters & Publications
Saadia Pharmaceuticals’ Team Publishes Rebutal on Vraylar® (AbbVie Pharmaceuticals) study on use for Bipolar I Disorder Maintenance
Learn More
May 3, 2024
Posters & Publications
Saadia Pharmaceuticals’ Team Presents Treatment-Resistant Major Depressive Disorder Study Poster at Hackensack Meridian School of Medicine 2024
Learn More
April 2, 2024
Posters & Publications
Saadia Pharmaceuticals’ Team Publishes Lybalvi® (Alkermes Pharmaceuticals) Case Series in Journal of Clinical Psychiatry Primary Care Companion for CNS Disorders
Learn More
March 30, 2024
In The News
Saadia Pharmaceuticals’ Team featured in Cosmopolitan Magazine
Learn More
Load More News
